Research Abstract
The presented review with 74 references covers most of the methods described for the analysis of Rivaroxaban (RXB); the first and selective oral direct inhibitor of activated factor X in its pure forms, in different pharmaceutical dosage forms and in biological fluids. The review covers the period from 2005 till now.
Research Department
Research Journal
Microchemical Journal
Research Member
Research Publisher
Elsevier
Research Rank
1
Research Vol
159
Research Website
https://www.sciencedirect.com/science/article/abs/pii/S0026265X20321184
Research Year
2020